Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM197 conjugate vaccine co-localizes with MHC II on the antigen processing cell surface

Vaccine

Volumn 27, Issue 24, 2009, Pages 3137-3144

  Lai, Zengzu ^a   Schreiber, John R ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen processing; Glycoconjugate; Pneumococcus; Polysaccharide

Indexed keywords

APC; BREFELDIN A; CARRIER PROTEIN; CHLOROQUINE; DIPHTHERIA TOXOID CRM197; GLYCOCONJUGATE VACCINE; HYDRAZIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CARBOHYDRATE ANALYSIS; CELL DEGENERATION; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL MOTION; CELL SURFACE; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; ENDOSOME; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN LOCALIZATION; STEM CELL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; BACTERIAL PROTEINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES; T-LYMPHOCYTES; VACCINES, CONJUGATE;

EID: 67349229802     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.064     Document Type: Article

References (32)

1. Cobb B.A., Wang Q., Tzianabos A.O., and Kasper D.L. Polysaccharide processing and presentation by the MHC II pathway. Cell 117 (2004) 677-687
2. Kalka-Moll W.M., Tzianabos A.O., Bryant P.W., Niemeyer M., Ploegh H.L., and Kasper D.L. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol 169 (2002) 6149-6153
3. Cowan M.J., Ammann A.J., Wara D.W., Howie V.M., Schultz L., Doyle N., et al. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 62 (1978) 721-727
4. Douglas R.M., Paton J.C., Duncan S.J., and Hansman D.J. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 148 (1983) 131-137
5. Kayhty H., Karanko V., Peltola H., and Makela P.H. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics 74 (1984) 857-865
6. Mond J.J., Lees A., and Snapper C.M. T cell-independent antigens type 2. Annu Rev Immunol 13 (1995) 655-692
7. Smith D.H., Peter G., Ingram D.L., Harding A.L., and Anderson P. Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae, type b. Pediatrics 52 (1973) 637-644
8. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
9. Black S.B., Shinefield H.R., Fireman B., Hiatt R., Polen M., Vittinghoff E., et al. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr Infect Dis J 10 (1991) 97-104
10. 197 in United States infants. Pediatrics 101 (1998) 604-611
11. 197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 18 (1999) 757-763
12. Schneerson R., Barrera O., Sutton A., and Robbins J.B. Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med 152 (1980) 361-376
13. Guttormsen H.K., Sharpe A.H., Chandraker A.K., Brigtsen A.K., Sayegh M.H., and Kasper D.L. Cognate stimulatory B-cell and T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect Immun 67 (1999) 6375-6384
14. Carel S., Bron C., and Corradin G. T-cell hybridoma specific for a cytochrome c peptide: specific antigen binding and interleukin 2 production. Proc Natl Acad Sci USA 80 (1983) 4832
15. Harding C.V., Roof R.W., Allen P.M., and Unanue E.R. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci USA 88 (1991) 2740-2744
16. Ortmann B., Martin S., von Bonin A., Schiltz E., Hoschiitzky H., and Weltzien H.U. Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. J Immunol 148 (1992) 1445
17. Unanue E.R., and Cerottini J.C. Antigen presentation. FASEB J 13 (1989) 2496-2502
18. + T cell cytokine response that correlates with isotype of anti-polysaccharide antibody. J Infect Dis 184 (2001) 931-935
19. 197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. J Infect Dis 187 (2003) 1629-1638
20. 197 conjugate vaccines in a murine model. Vaccine 19 (2000) 1159-1166
21. 197 differs depending on the serotype of the attached polysaccharide. Infect Immun 71 7 (2003) 4186-4189
22. Hanna N., and Leskowitz S. Structural requirements for in vivo and in vitro immunogenicity in hapten-specific delayed hypersensitivity. Cell Immunol 7 (1973) 189
23. Ishioka G.Y., Lamont A.G., Thomson D., Bulbow N., Gaeta F.C., Sette A., et al. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol 148 (1992) 2446-2451
24. Stein K.E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 165 Suppl. 1 (1992) S49-S52
25. Harding C.V., Kihlberg J., Elofsson M., Magnusson G., and Unanue E.R. Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol 151 5 (1993) 2419-2425
26. Muthukkumar S., and Stein K.E. Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice. Vaccine 22 (2004) 1290-1299
27. Lotan R., Debray H., Cacan M., Cacan R., and Sharon N. Labeling of soybean agglutinin by oxidation with sodium periodate followed by reduction with sodium borohydride. J Biol Chem 250 5 (1975) 1955-1957
28. Lutz M.B., Kukutsch N., Ogilvie A., RoBner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223 (1999) 77-92
29. Granoff D.M., Holmes S.J., Belshe R.B., Osterholm M.T., McHugh J.E., and Anderson E.L. Effect of carrier protein priming on antibody response to Haemophilus influenzae type b conjugate vaccines in infants. JAMA 272 (1994) 1116-1121
30. Greenberg D.P., Lieberman J.M., Marcy S.M., Wong V.K., Partridge S., Chang S.J., et al. Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b vaccines. Pediatrics 126 (1995) 206-211
31. Jensen T., Hansen P., Galli-Stampino L., Mouritsen S., Frische K., Meinjohanns E., et al. Carbohydrate and peptide specificity of MHC class II restricted T cell hybridomas raised against O-glycosylated self peptide. J Immunol 158 (1997) 3769-3778
32. Porcelli S.A., Morita C.T., and Modlin R.L. T cell recognition of non-peptide antigens. Curr Opin Immunol 8 (1996) 510-516